BIG
AXSM icon

Brooklyn Investment Group’s Axsome Therapeutics AXSM Stock Holding History

Brooklyn Investment Group’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-37
Closed -$3.86K – 853
2025
Q2 		$3.86K Buy
37
+6
+19% +$635 ﹤0.01% 2576
2025
Q1 		$3.62K Buy
31
+11
+55% +$1.25K ﹤0.01% 1947
2024
Q4 		$1.69K Buy
+20
New +$1.84K ﹤0.01% 1506

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brooklyn Investment Group's AXSM Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Axsome Therapeutics (AXSM) in Q3 2025, closing a stake of 37 shares — an estimated $3.86K sold.

Brooklyn Investment Group first reported a position in AXSM in Q4 2024 and held it in 3 quarters. The position peaked at $3.86K in Q2 2025. 355 funds tracked by Wall St. Rank hold AXSM as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Axsome Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 37 Axsome Therapeutics shares in Q3 2025, an estimated $3.86K.
  • Brooklyn Investment Group first reported a position in Axsome Therapeutics in Q4 2024 and held it in 3 quarters.
  • Brooklyn Investment Group's Axsome Therapeutics position peaked at $3.86K in Q2 2025.
  • 355 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.